Effects of spironolactone on extrasystoles and heart rate variability in haemodialysis patients: a randomised crossover trial

BACKGROUND: Spironolactone treatment reduces mortality in haemodialysis (HD) patients. The objective of this study was to evaluate if spironolactone affects cardiac electric activity in this population. METHODS: Participants were randomised to start with spironolactone 50 mg daily or observation (12...

Descripción completa

Detalles Bibliográficos
Autores principales: Eklund, Michael, Hellberg, Olof, Furuland, Hans, Cao, Yang, Nilsson, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Academia 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886278/
https://www.ncbi.nlm.nih.gov/pubmed/33613861
http://dx.doi.org/10.48101/ujms.v126.5660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886278/
https://www.ncbi.nlm.nih.gov/pubmed/33613861
http://dx.doi.org/10.48101/ujms.v126.5660

Ejemplares similares